Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioNTech SE - American Depositary Shares
(NQ:
BNTX
)
94.14
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
37
Open
94.14
Bid (Size)
92.10 (100)
Ask (Size)
96.99 (100)
Prev. Close
94.14
Today's Range
94.14 - 94.14
52wk Range
81.20 - 129.27
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
December 22, 2025
As of today, December 22, 2025, Pfizer Inc. (NYSE: PFE) stands as a case study in corporate reinvention and the brutal reality of the post-pandemic "hangover." Once the darling of the global healthcare...
Via
PredictStreet
Topics
Economy
Intellectual Property
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
December 22, 2025
As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global...
Via
PredictStreet
Topics
Earnings
Initial Public Offering
Intellectual Property
Performance
YTD
-18.4%
-18.4%
1 Month
-2.5%
-2.5%
3 Month
-4.2%
-4.2%
6 Month
-10.4%
-10.4%
1 Year
-17.1%
-17.1%
More News
Read More
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
December 18, 2025
From
BioNTech SE
Via
GlobeNewswire
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
December 16, 2025
Via
MarketMinute
Topics
Intellectual Property
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
December 09, 2025
From
BioNTech SE
Via
GlobeNewswire
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
December 06, 2025
From
BioNTech SE
Via
GlobeNewswire
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
December 03, 2025
From
BioNTech SE
Via
GlobeNewswire
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths
↗
December 01, 2025
Via
Investor's Business Daily
Topics
Death
2 Top Dividend Stocks to Buy and Hold
↗
November 30, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
BioNTech (BNTX) Q3 2025 Earnings Call Transcript
↗
November 27, 2025
Via
The Motley Fool
Topics
Earnings
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
November 26, 2025
From
BioNTech SE
Via
GlobeNewswire
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
↗
November 13, 2025
Via
Benzinga
BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company
↗
November 13, 2025
Via
Stocktwits
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership
↗
November 03, 2025
Via
Benzinga
BioNTech SE (NASDAQ:BNTX) Reports Mixed Q3 2025 Results with Major Revenue Beat and Quarterly Loss
↗
November 03, 2025
Via
Chartmill
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
November 03, 2025
From
BioNTech SE
Via
GlobeNewswire
BioNTech to Host Innovation Series R&D Day on November 11, 2025
October 28, 2025
From
BioNTech SE
Via
GlobeNewswire
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
October 27, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
October 27, 2025
From
BioNTech SE
Via
GlobeNewswire
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever
↗
October 25, 2025
Via
The Motley Fool
Topics
Government
Intellectual Property
World Trade
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
October 22, 2025
From
BioNTech SE
Via
GlobeNewswire
Beyond The Numbers: 7 Analysts Discuss BioNTech Stock
↗
October 10, 2025
Via
Benzinga
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
October 08, 2025
Via
MarketMinute
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
↗
October 08, 2025
Via
The Motley Fool
Topics
Government
World Trade
Frequently Asked Questions
Is BioNTech SE - American Depositary Shares publicly traded?
Yes, BioNTech SE - American Depositary Shares is publicly traded.
What exchange does BioNTech SE - American Depositary Shares trade on?
BioNTech SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BioNTech SE - American Depositary Shares?
The ticker symbol for BioNTech SE - American Depositary Shares is BNTX on the Nasdaq Stock Market
What is the current price of BioNTech SE - American Depositary Shares?
The current price of BioNTech SE - American Depositary Shares is 94.14
When was BioNTech SE - American Depositary Shares last traded?
The last trade of BioNTech SE - American Depositary Shares was at 12/23/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
